Weekly equity-report by epic research 8 april 2013
1. WEEKLY NEWS
India can grow by 6.5% this fiscal: Montek
India can grow by 6.5 percent in the current fiscal during
which big projects are likely to get clearances from CCI,
Planning Commission Deputy Chairman Montek Singh
Ahluwalia said today.Do you believe in one year (2013-
14) that it (growth rate can go up by 1.5 percentage
points, the short answer is absolutely yes," he said
addressing Hero Mindmine summit here. According to
the Central Statistical Organisation's (CSO) advance
estimates, Indian economy is projected to grow by 5
percent in 2012-13.The Budget has projected an
economic growth rate of 6.5 percent in 2013-14, 1.5
percentage point higher than the estimated growth in
WEEKLY EQUITY the last financial year."This year should be better
NEWSLETTER primarily because on these implementation front, we
8TH APRIL 2013 would see moves. There is no sign at the moment of
strong recovery but I think there is sign of bottoming up
(of decline in economy).
"CIL to continue 50% supply; NTPC says
generation to pick up
MARKET UPDATE:- The Coal Ministry today assured that half of fuel supply
to NTPC would continue for the time being while the
Nifty down by 130 pts
power producer said generation will pick up
and settle at 5553.25
gradually.The development comes amidst feud between
Bank Nifty down by 260 Coal India and NTPC over quality of fuel being supplied.
pts at 11098.95 The situation got aggravated after NTPC lowered
generation saying supply from CIL was of poor quality
and inadequate, stoking fears of power cuts ahead of
peak summer.
http://www.epicresearch.co 09752199966
09993959693
2. MARKET ANALYSIS
KEY BENCHMARK INDICES EDGED LOWER IN THE WEEK ENDED FRIDAY, 5 APRIL 2013 AFTER A PRIVATE
SURVEY SHOWED GROWTH IN THE SERVICES SECTOR HIT 17-MONTH LOW IN MARCH 2013. MARKET
DECLINED IN THREE OF FIVE TRADING SESSIONS IN THE WEEK. THE S&P BSE MID-CAP AND THE S&P
BSE SMALL-CAP INDICES OUTPERFORMED THE SENSEX DURING THE WEEK.
IN THE WEEK ENDED FRIDAY, 5 APRIL 2013, THE 30-SHARE S&P BSE SENSEX FELL 385.54 POINTS OR
2.05% TO 18,450.23. THE 50-UNIT CNX NIFTY DECLINED 129.30 POINTS OR 2.27% TO 5,553.25.
THE S&P BSE MID-CAP INDEX ROSE 0.04% AND THE S&P BSE SMALL-CAP INDEX ADVANCED 1.89%.
BOTH THESE INDICES OUTPERFORMED THE SENSEX.
FOREIGN INSTITUTIONAL INVESTORS (FIIS) BOUGHT SHARES WORTH RS 639.30 CRORE IN APRIL 2013 SO
FAR (TILL 4 APRIL 2013). FIIS HAD PURCHASED SHARES WORTH RS 9124.30 CRORE IN MARCH 2013.
FIIS HAVE PURCHASED SHARES WORTH NET RS 56261.70 CRORE IN 2013 SO FAR (TILL 4 APRIL 2013).
FIIS BOUGHT SHARES WORTH NET RS 128359.80 CRORE IN CALENDAR 2012.
FROM 30-SHARE SENSEX PACK, 21 STOCKS DECLINED AND REST OF THEM GAINED THE WEEK ENDED
FRIDAY, 5 APRIL 2013.
METAL SHARES EDGED LOWER. TATA STEEL (DOWN 1.22%), HINDALCO INDUSTRIES (DOWN 1.86%), AND
JINDAL STEEL & POWER (DOWN 3.86%) DECLINED.
.
EXPERT OPINION
NIFTY WEEKLY PIVOTS
NIFTY BANK NIFTY
Nifty looks Bearish Bank Nifty looks Bearish
Strategy: Sell on rise Strategy: Sell on rise
Support:5500 Support: 11000
Resistance: 5600 Resistance: 11200
NIFTY WEEKLY PIVOTS
PIVOTS R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 6273 6053 5833 5693 5613 5473 5393 5173 4953
http://www.epicresearch.co 09752199966
4. GAINERS AND LOOSERS
WEEKLY NIFTY GAINERS
SCRIPS RATE VOL. (000) PR. NET % CHANGE
CLOSE CHANGE
Maruti
1406.30 280.42 1283.80 122.50 9.54
Suzuki
Sun Pharma 859.35 264.82 812.65 46.70 5.75
Dr Reddys 1911.55 379.44 1825.90 85.65 4.69
ONGC 314.30 1487.10 308.85 5.45 1.76
Coal India 309.25 989.91 305.10 4.15 1.36
WEEKLY NIFTY LOOSERS
.
SCRIPS RATE VOL. PR. CLOSE NET % CHANGE
(000) CHANGE
DLF 232.8 13591.99 253.2 -20.4 -8.06
Bharti Airtel 270.25 1452.02 293.65 -23.4 -7.97
NMDC 124.85 2095.18 135.15 -10.3 -7.62
HDFC 770.8 1514.57 825.2 -54.4 -6.59
Axis Bank 1229.55 981.34 1314.9 -85.35 -6.49
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.